Stay updated with breaking news from Bio Path. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a report issued on Friday morning. The brokerage issued a sell rating on the stock. Separately, Roth Capital reiterated a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Price Performance Shares of Bio-Path stock opened at $1.39 […]
StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research note released on Thursday. The firm issued a sell rating on the stock. Separately, Roth Capital reaffirmed a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Stock Performance Shares of NASDAQ BPTH opened at $1.42 […]
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research note published on Thursday. The firm issued a sell rating on the stock. Separately, Roth Capital reiterated a buy rating on shares of Bio-Path in a research report on Friday, March 17th. Bio-Path Price Performance BPTH stock opened at $1.42 on […]
StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research note issued to investors on Wednesday. The firm issued a sell rating on the stock. Separately, Roth Capital restated a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Stock Down 18.7 % NASDAQ:BPTH opened at […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Rating) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 64,100 shares, a drop of 9.7% from the February 28th total of 71,000 shares. Based on an average trading volume of 38,000 shares, the days-to-cover ratio is […]